Education
About Us
Working with TipRanks
Follow Us
aXichem AB Class A (SE:AXIC.A)
:AXIC.A
RESEARCH TOOLSreports
Top Page
aXichem AB Class A
(Frankfurt:AXIC.A)
49Neutral
aXichem AB Class A (AXIC.A) vs. S&P 500 (SPY)
Market Cap
kr75.08M
Dividend YieldN/A
Average Volume (3M)37.49K
Price to Earnings (P/E)―
Beta (1Y)-0.54
Revenue Growth373.74%
EPS Growth46.13%
CountrySE
Employees6
SectorBasic Materials
Sector Strength60
IndustryChemicals
Share Statistics
EPS (TTM)-0.53
Shares Outstanding59,114,906
10 Day Avg. Volume14,665
30 Day Avg. Volume37,494
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
aXichem AB Class A Business Overview & Revenue Model
Company DescriptionaXichem AB Class A (AXIC.A) is a biotechnology company based in Sweden that specializes in the development and commercialization of natural analog products. The company's core focus is on producing synthetic capsaicin through its proprietary technology, which is used as an active ingredient in various sectors including health, feed, and food industries. aXichem's products are designed to offer natural solutions that enhance performance, safety, and sustainability.
How the Company Makes MoneyaXichem AB generates revenue primarily by selling its synthetic capsaicin products to companies operating in the health, feed, and food industries. The company's key revenue streams include direct sales of its products to manufacturers who incorporate these ingredients into their own offerings, such as dietary supplements, animal feed, and food products. Additionally, aXichem may engage in licensing agreements and partnerships with other companies to expand the reach and application of its technology. These collaborations can provide additional income through licensing fees and shared revenue models. Factors contributing to aXichem's earnings include the growing demand for natural and sustainable ingredients in various industries and the company's ability to innovate and adapt its products to meet market needs.
aXichem AB Class A Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | |||||
| TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 7.45M | 1.81M | 5.01M | 4.36M | 1.23M | 343.00K | Gross Profit |
| 659.00K | 1.41M | 3.82M | 909.00K | 596.00K | 40.00K | EBIT |
| -11.84M | -17.32M | -14.54M | -15.07M | -13.51M | -12.44M | EBITDA |
| -12.14M | -15.10M | -12.44M | -13.49M | -12.01M | -11.07M | Net Income Common Stockholders |
| -18.03M | -20.81M | -17.26M | -15.09M | -13.52M | -12.68M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 2.71M | 4.31M | 6.55M | 9.45M | 12.04M | 30.81M | Total Assets |
| 89.39M | 61.49M | 61.25M | 58.77M | 55.75M | 68.97M | Total Debt |
| 19.12M | 10.27M | 18.76M | 0.00 | 0.00 | 0.00 | Net Debt |
| 16.41M | 5.96M | 12.21M | -9.45M | -12.04M | -30.81M | Total Liabilities |
| 25.20M | 12.96M | 20.92M | 2.47M | 2.10M | 1.82M | Stockholders Equity |
| 64.17M | 48.51M | 40.31M | 56.30M | 53.65M | 67.15M |
| Cash Flow | Free Cash Flow | ||||
| -14.63M | -20.78M | -21.71M | -20.32M | -18.93M | -16.12M | Operating Cash Flow |
| -11.55M | -15.68M | -19.10M | -15.60M | -11.69M | -12.29M | Investing Cash Flow |
| -3.72M | -5.10M | -2.61M | -4.73M | -7.23M | -3.85M | Financing Cash Flow |
| 16.89M | 18.54M | 18.80M | 17.73M | 0.00 | 43.18M |
aXichem AB Class A Technical Analysis
Positive
1.27
Price Trends
1.25
Positive
1.27
Positive
1.28
Negative
Market Momentum
<0.01
Negative
54.00
Neutral
78.05
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:AXIC.A, the sentiment is Positive. The current price of 1.27 is above the 20-day moving average (MA) of 1.22, above the 50-day MA of 1.25, and below the 200-day MA of 1.28, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 54.00 is Neutral, neither overbought nor oversold. The STOCH value of 78.05 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:AXIC.A.
aXichem AB Class A Peers Comparison
Overall Rating
UnderperformOutperform
Sector (49)
Financial Indicators
Performance Comparison
SE:AXIC.A
aXichem AB Class A
1.27
0.07
6.28%
SE:NEXAM
Nexam Chemical Holding AB
3.30
0.29
9.63%
SE:TRIBO.B
Triboron International AB Class B
0.31
0.02
5.17%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.